No Borders Inc. (NBDR) Launches Revolutionary Blockchain-Based ‘CBD LabChain’ to Deliver Secure, Transparent and Verified Lab Results
- CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results
- No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products
- No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth
No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues and shareholder value, has launched a revolutionary blockchain utilization platform specifically designed for the CBD industry. No Borders CEO and Chairman Joseph Snyder recently presented the company’s CBD LabChain platform to a wide audience of industry leaders and professionals attending Blockchain Expo 2019 in San Francisco (http://nnw.fm/AYsa8).
“I am very proud to share our product launch of CBD LabChain,” Snyder stated in the official launch video (http://nnw.fm/wYp98). “Our product line, NoBordersNaturals.com, is in our humble opinion the finest line of CBD products on the market today. As of today, CBD LabChain is an immutable, secure, permanent record of all of the data, lab test results, THC amounts, CBD amounts, and other pertinent spectrum result that are in the product line that we sell to our consumers today.”
No Borders Naturals is currently the only company in the world to record 100% of its third-party lab tests on the www.CBDLabChain.com platform. However, CBD LabChain, built with a Platform-as-a-Service (PaaS) revenue model, is now available to existing market participants to record their lab test results for a per-test fee, Snyder said. Results of lab test results are easily accessible via QR Code linkage.
No Borders recently reported its family of companies achieved quarter-over-quarter revenue growth of 25.57%, increasing gross margins by 7.44% to 42.47% in Q3 2019, versus 35.03% in the previous quarter. No Borders also completed and submitted its quarterly filings early, which is now a company tradition and one that demonstrates to stakeholders an ironclad commitment to internal brand growth.
“Clearly, this filing shows that the Company is deploying capital to its brands and businesses at almost a 100% rate,” Cynthia Tanabe, COO of No Borders Inc., stated in a news release (http://nnw.fm/w2ouI). “This is a strong indicator of how much faster and farther the NBDR brands can go with the addition of capital through the Company’s recent SEC filings.”
For more information, visit the company’s website at www.NBDR.co
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results
- No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products
- No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth
No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues and shareholder value, has launched a revolutionary blockchain utilization platform specifically designed for the CBD industry. No Borders CEO and Chairman Joseph Snyder recently presented the company’s CBD LabChain platform to a wide audience of industry leaders and professionals attending Blockchain Expo 2019 in San Francisco (http://nnw.fm/AYsa8).
“I am very proud to share our product launch of CBD LabChain,” Snyder stated in the official launch video (http://nnw.fm/wYp98). “Our product line, NoBordersNaturals.com, is in our humble opinion the finest line of CBD products on the market today. As of today, CBD LabChain is an immutable, secure, permanent record of all of the data, lab test results, THC amounts, CBD amounts, and other pertinent spectrum result that are in the product line that we sell to our consumers today.”
No Borders Naturals is currently the only company in the world to record 100% of its third-party lab tests on the www.CBDLabChain.com platform. However, CBD LabChain, built with a Platform-as-a-Service (PaaS) revenue model, is now available to existing market participants to record their lab test results for a per-test fee, Snyder said. Results of lab test results are easily accessible via QR Code linkage.
No Borders recently reported its family of companies achieved quarter-over-quarter revenue growth of 25.57%, increasing gross margins by 7.44% to 42.47% in Q3 2019, versus 35.03% in the previous quarter. No Borders also completed and submitted its quarterly filings early, which is now a company tradition and one that demonstrates to stakeholders an ironclad commitment to internal brand growth.
“Clearly, this filing shows that the Company is deploying capital to its brands and businesses at almost a 100% rate,” Cynthia Tanabe, COO of No Borders Inc., stated in a news release (http://nnw.fm/w2ouI). “This is a strong indicator of how much faster and farther the NBDR brands can go with the addition of capital through the Company’s recent SEC filings.”
For more information, visit the company’s website at www.NBDR.co
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
